CASES (Canadian Approaches to Stroke Prevention in Atrial Arrhythmias) is a continuing educational program for healthcare professionals for primary care on the management of patients with atrial fibrillation, with particular reference to anticoagulation. The program is practical, case-based and healthcare professional-friendly. Participants can choose cases from a selection of ten realistic short patient case scenarios.

Each case scenario is presented as an overall question or statement that needs addressing, followed by a case profile, key discussion points, 4-5 slides of supporting data, and culminating in some expert recommendations. The case scenarios vary from 5-10 total slides per case.

This assessment-based program is focused on those patients living with rheumatoid arthritis (RA) with additional considerations.

Four modules investigate specific issues in RA, in particular, the implications of cardiovascular disease (CVD), depression, travelling with RA, and RA patient communication strategies. Learner engagement within the program is encouraged through a series of interactive “self checks”.

Experts weigh in to provide insight and advice to clinicians to enhance practical skill and decision-making.

Second in a series of e-CME programs, this interactive course clarifies the major differences between opioid drugs and medicinal prescription cannabinoids. The case-based scenario emphasizes the synergies between opioids and cannabinoids, the important ability to reduce opioid dosages in patients. Learners will have the opportunity to challenge themselves through participating in an interesting case review, including “self checks” and decision making.

SHIFT is aimed at improving physicians’ understanding of the recent advances in managing anticoagulation and stroke prevention in atrial fibrillation (AF) patients.  6 distinct modules involve reviewing the pathophysiology and burden of stroke in patients with AF, including identifying risk factors and improving the use of clinical assessment tools.  The program also investigates challenges and limitations of current therapies, while reviewing emerging data for a new class of oral anticoagulant agents, and the role in stroke prevention in patients with AF.

ACE II 2010 is the continuation to the national 2009 live accredited lecture series, which provided an introduction to the current and potential use of cannabinoid therapies in clinical practice.

The ACE II 2010 learning module contains a concise review of the evidence supporting cannabinoids and potential uses in patients suffering from specific conditions including practical strategies to monitor patients on cannabinoids. One module will provide insightful information, reviewing medical cannabis (smoked) recommendations and regulations to help clinicians understand the MMAR program in Canada.

Participants can explore potential scenarios for cannabinoid application in clinical practice through three real life, case-based studies. 

The Rheum To Grow Program is comprised of four interactive modules which are focused on a number of specific, controversial issues in rheumatoid arthritis (RA) patients, including intriguing case-based scenarios.  

The program includes a thorough review of the routine use of patient assessments along with addressing interesting and controversial issues related to treating RA patients with malignancies, and those who have RA and the implications in treating while considering reproduction.  

This program also provides communication strategies for clinicians to employ with their RA patients to help patients with adherence and understanding of their disease.